Generate Biomedicines, Inc. Common Stock (GENB)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Market Cap
- $1.8B
About Generate Biomedicines, Inc. Common Stock
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
SentiSense also tracks daily options readings for Generate Biomedicines, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Generate Biomedicines, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.